Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A multi-site, randomized, double-blind, placebo-controlled study to evaluate the safety and immunogenicity of trehalose-reformulated peru-15 (Choleragarde)vaccine [cholera vaccine live attenuated] given simultaneously with measles vaccine [measles virus vaccine live] in healthy Indian and Bangladeshi infants.

Next Previous
X
Search
Trial Profile

A multi-site, randomized, double-blind, placebo-controlled study to evaluate the safety and immunogenicity of trehalose-reformulated peru-15 (Choleragarde)vaccine [cholera vaccine live attenuated] given simultaneously with measles vaccine [measles virus vaccine live] in healthy Indian and Bangladeshi infants.

Status: Discontinued
Phase of Trial: Phase II

Latest Information Update: 10 Nov 2021

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Cholera vaccine live attenuated (Primary) ; Measles virus vaccine live (Primary)
  • Indications Cholera; Measles; Vibrio infections
  • Focus Adverse reactions; Pharmacodynamics

    • Most Recent Events

    • 31 Jul 2012 Actual end date (Jul 2012) added as reported by ClinicalTrials.gov.
    • 31 Jul 2012 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
    • 29 Mar 2012 Planned end date changed from 1 May 2011 to 1 Sep 2012 as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top